141 related articles for article (PubMed ID: 38199216)
1. Injectable alginate-based in situ self-healable transparent hydrogel as a vitreous substitute with a tamponading function.
Choi G; An SH; Choi JW; Rho MS; Park WC; Jeong WJ; Cha HJ
Biomaterials; 2024 Mar; 305():122459. PubMed ID: 38199216
[TBL] [Abstract][Full Text] [Related]
2. A highly transparent tri-polymer complex
Yadav I; Purohit SD; Singh H; Das N; Roy P; Mishra NC
Biomed Mater; 2021 Oct; 16(6):. PubMed ID: 34525462
[TBL] [Abstract][Full Text] [Related]
3. A cross-linked hyaluronic acid hydrogel (Healaflow(®)) as a novel vitreous substitute.
Barth H; Crafoord S; Andréasson S; Ghosh F
Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):697-703. PubMed ID: 26743755
[TBL] [Abstract][Full Text] [Related]
4. [Vitreous Substitute in Retinal Detachment Surgery - Why We Need a New Tamponade Strategy].
Szurman P
Klin Monbl Augenheilkd; 2017 Sep; 234(9):1094-1102. PubMed ID: 28895627
[TBL] [Abstract][Full Text] [Related]
5. Biocompatibility of polyvinyl alcohol/trisodium trimetaphosphate as vitreous substitute in experimental vitrectomy model in rabbits.
de Oliveira RA; Muralha FP; Grupenmacher AT; de Araújo Morandim-Giannetti A; Bersanetti PA; Maia M; Magalhães Junior O
J Biomed Mater Res B Appl Biomater; 2022 Feb; 110(2):460-466. PubMed ID: 34328263
[TBL] [Abstract][Full Text] [Related]
6. A New Retinal Detachment Treatment Model for Evaluation of Vitreous Tamponades.
Barth H; Crafoord S; Ghosh F
Curr Eye Res; 2021 Mar; 46(3):373-379. PubMed ID: 32806983
[No Abstract] [Full Text] [Related]
7. A novel vitreous substitute of using a foldable capsular vitreous body injected with polyvinylalcohol hydrogel.
Feng S; Chen H; Liu Y; Huang Z; Sun X; Zhou L; Lu X; Gao Q
Sci Rep; 2013; 3():1838. PubMed ID: 23670585
[TBL] [Abstract][Full Text] [Related]
8. Rabbit study of an in situ forming hydrogel vitreous substitute.
Swindle-Reilly KE; Shah M; Hamilton PD; Eskin TA; Kaushal S; Ravi N
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4840-6. PubMed ID: 19324846
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of two different thiol-modified crosslinked hyaluronate formulations as vitreous replacement compared to silicone oil in a model of retinal detachment.
Schnichels S; Schneider N; Hohenadl C; Hurst J; Schatz A; Januschowski K; Spitzer MS
PLoS One; 2017; 12(3):e0172895. PubMed ID: 28248989
[TBL] [Abstract][Full Text] [Related]
10. Injectable self-crosslinking hydrogels based on hyaluronic acid as vitreous substitutes.
Yu S; Wang S; Xia L; Hu H; Zou M; Jiang Z; Chi J; Zhang Y; Li H; Yang C; Liu W; Han B
Int J Biol Macromol; 2022 May; 208():159-171. PubMed ID: 35301003
[TBL] [Abstract][Full Text] [Related]
11. Vitreous substitutes: An overview of the properties, importance, and development.
Yadav I; Purohit SD; Singh H; Bhushan S; Yadav MK; Velpandian T; Chawla R; Hazra S; Mishra NC
J Biomed Mater Res B Appl Biomater; 2021 Aug; 109(8):1156-1176. PubMed ID: 33319466
[TBL] [Abstract][Full Text] [Related]
12. Polymeric hydrogels as a vitreous replacement strategy in the eye.
Lin Q; Lim JYC; Xue K; Su X; Loh XJ
Biomaterials; 2021 Jan; 268():120547. PubMed ID: 33307366
[TBL] [Abstract][Full Text] [Related]
13. Stable oxime-crosslinked hyaluronan-based hydrogel as a biomimetic vitreous substitute.
Baker AEG; Cui H; Ballios BG; Ing S; Yan P; Wolfer J; Wright T; Dang M; Gan NY; Cooke MJ; Ortín-Martínez A; Wallace VA; van der Kooy D; Devenyi R; Shoichet MS
Biomaterials; 2021 Apr; 271():120750. PubMed ID: 33725584
[TBL] [Abstract][Full Text] [Related]
14. The feasibility study of an in situ marine polysaccharide-based hydrogel as the vitreous substitute.
Jiang X; Peng Y; Yang C; Liu W; Han B
J Biomed Mater Res A; 2018 Jul; 106(7):1997-2006. PubMed ID: 29569838
[TBL] [Abstract][Full Text] [Related]
15. Injectable in situ cross-linking hyaluronan hydrogel for easier removal of posterior vitreous cortex in vitrectomy.
Hisatomi T; Tachibana T; Mori K; Ishikawa K; Ishibashi T; Sonoda KH; Uchio E; Watanabe I; Suzuki K; Iida M
Jpn J Ophthalmol; 2024 Mar; 68(2):146-156. PubMed ID: 38311687
[TBL] [Abstract][Full Text] [Related]
16. Heavy silicone oil versus standard silicone oil as vitreous tamponade in inferior PVR (HSO Study): design issues and implications.
Joussen AM; Kirchhof B; Schrage N; Ocklenburg C; Hilgers RD;
Acta Ophthalmol Scand; 2007 Sep; 85(6):623-30. PubMed ID: 17408389
[TBL] [Abstract][Full Text] [Related]
17. Foldable capsular vitreous body implantation for treatment of traumatic retinal detachment: two case reports.
Zeng B; Wang Q; Sui G; Wang M; Xie W; Fu J
J Int Med Res; 2021 Feb; 49(2):300060521990257. PubMed ID: 33563057
[TBL] [Abstract][Full Text] [Related]
18. Reattachment After Foldable Capsular Vitreous Body Implantation in Severe Retinal Detachment Eyes.
Chen S; Tian M; Zhang L; Hu C; Liu K; Qin B; Liu S
Transl Vis Sci Technol; 2021 Sep; 10(11):8. PubMed ID: 34491287
[TBL] [Abstract][Full Text] [Related]
19. Retinal-detachment repair and vitreous-like-body reformation via a thermogelling polymer endotamponade.
Liu Z; Liow SS; Lai SL; Alli-Shaik A; Holder GE; Parikh BH; Krishnakumar S; Li Z; Tan MJ; Gunaratne J; Barathi VA; Hunziker W; Lakshminarayanan R; Tan CWT; Chee CK; Zhao P; Lingam G; Loh XJ; Su X
Nat Biomed Eng; 2019 Aug; 3(8):598-610. PubMed ID: 30962587
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Biocompatibility of a Highly Viscously Thiol-Modified Cross-Linked Hyaluronate as a Novel Vitreous Body Substitute.
Hurst J; Rickmann A; Heider N; Hohenadl C; Reither C; Schatz A; Schnichels S; Januschowski K; Spitzer MS
Front Pharmacol; 2022; 13():817353. PubMed ID: 35308238
[No Abstract] [Full Text] [Related]
[Next] [New Search]
